|
|
 |
Trial Information
Summary: Behavioral modifications and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
A 52-Week, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Overweight and Obese Patients with Type 2 Diabetes Mellitus Managed with Oral Hypoglycemic Agent(s)
BLOOM-DM
Behavioral modifications and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
A 52-Week, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Overweight and Obese Patients with Type 2 Diabetes Mellitus Managed with Oral Hypoglycemic Agent(s)
The MGH Weight Center is now enrolling for a new clinical trial for the treatment of diabetes and obesity!
You may be eligible to take part in a clinical research study with an experimental drug for the treatment of diabetes and obesity. This medication has shown to help short-term (12-week) weight loss in previous studies and will be tested to determine effectiveness for long-term weight loss.
The study will run for 64 weeks. Study related exams and drug as well as periodic nutritional counseling will be provided free of charge for those who qualify. Remuneration of up to $700 will also be provided.
The study will consist of:
• taking a study drug or placebo (sugar pill - no active medicine or drug ) for 1 year
If you take part in this study, you may not get the study drug
• individual nutritional counseling
• monthly visits to the MGH Weight Center to meet with the study team and dietitian
Eligible subjects must:
• be between the ages of 18 and 65
• have Type-II diabetes
• be overweight
• willing and able to commit to the study and taking the medication (or placebo) for 1 year
Institution – Massachusetts General Hospital, Boston, MA
Principal Investigator – Lee M. Kaplan, MD, PhD
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name – Carolyn Robinson, Research Coordinator
Email – crobinson12@partners.org
Phone – 617-724-9616
|
Contact:
Carolyn A Robinson, CRC
Massachusetts General Hospital (MGH)
55 Fruit Street
Boston, MA 02114
Telephone: 617-724-9616
Email:
|
|
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 30, 2008 at 5:00:10 PM
|
|
|
